Tyra Biosciences, Inc.
NASDAQ:TYRA
16.42 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 99.49 | 254.366 | 58.006 | 215.652 | 232.413 | 241.701 | 251.213 | 263.211 | 275.107 | 292.499 | 302.182 | 312.823 | 135.204 | 140.638 | 15.224 |
| Short Term Investments
| 274.306 | 128.096 | 145.463 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 373.796 | 382.462 | 203.469 | 215.652 | 232.413 | 241.701 | 251.213 | 263.211 | 275.107 | 292.499 | 302.182 | 312.823 | 135.204 | 140.638 | 15.224 |
| Net Receivables
| 1.9 | 1.5 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.878 | 6.816 | 7.502 | 8.978 | 8.333 | 5.008 | 6.075 | 4.26 | 2.192 | 1.526 | 1.875 | 0.678 | 0.217 | 0.19 | 0.057 |
| Total Current Assets
| 378.574 | 390.778 | 211.671 | 224.63 | 240.746 | 241.701 | 257.288 | 267.471 | 277.299 | 294.025 | 304.057 | 313.501 | 135.421 | 140.828 | 15.281 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 8.194 | 8.005 | 8.154 | 7.383 | 7.4 | 3.472 | 3.543 | 3.642 | 3.737 | 3.584 | 2.089 | 1.908 | 1.923 | 0.467 | 0.466 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.505 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.243 | 0.243 | 0 | 0.243 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.262 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.693 | 4.958 | 5.032 | 5.345 | 0.866 | 3.874 | 4.35 | 3.872 | 5.082 | 0.362 | 0.05 | 0.318 | 2.574 | 0.271 | 0.264 |
| Total Non-Current Assets
| 13.887 | 13.963 | 14.186 | 13.728 | 9.266 | 8.346 | 8.893 | 8.514 | 9.819 | 4.946 | 2.644 | 2.469 | 4.497 | 0.981 | 0.73 |
| Total Assets
| 392.461 | 404.741 | 225.857 | 238.358 | 250.012 | -101.311 | 266.181 | 275.985 | 287.118 | 298.971 | 306.701 | 315.97 | 139.918 | 141.809 | 16.011 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 1.577 | 2.879 | 4.662 | 2.308 | 1.44 | 1.28 | 1.145 | 2.747 | 2.343 | 1.356 | 0.599 | 2.068 | 1.875 | 0.841 | 0.664 |
| Short Term Debt
| 0.383 | 0.37 | 0.28 | 0.148 | 0.144 | 0.144 | 0.14 | 0.127 | 0.123 | 0.119 | 0.202 | 0.135 | 0.136 | 0.088 | 0.142 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| -0.383 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 8.805 | 5.467 | 10.391 | 7.691 | 3.821 | 0.834 | 4.416 | 2.615 | 2.989 | 3.426 | 2.815 | 2.565 | 1.738 | 0.606 | 1.052 |
| Total Current Liabilities
| 10.382 | 8.716 | 15.333 | 10.147 | 5.405 | 2.258 | 5.701 | 5.489 | 5.455 | 4.901 | 3.616 | 4.768 | 3.749 | 1.535 | 1.858 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 6.016 | 6.117 | 6.216 | 5.964 | 5.927 | 2.444 | 2.482 | 2.514 | 2.549 | 2.583 | 0.981 | 1.037 | 1.091 | 157.274 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.262 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.262 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.02 | 0.029 | 0.046 | 0.077 | 0.108 | 0.139 | 0.169 | 0.226 | 0.261 | 0.303 | 0.105 | 0.434 | 157.745 | 0.522 | 27.791 |
| Total Non-Current Liabilities
| 6.036 | 6.146 | 6.262 | 6.041 | 6.035 | 2.583 | 2.651 | 2.74 | 2.81 | 2.886 | 1.348 | 1.471 | 158.836 | 157.796 | 27.791 |
| Total Liabilities
| 16.418 | 14.862 | 21.595 | 16.188 | 11.44 | 2.258 | 8.352 | 8.229 | 8.265 | 7.787 | 4.964 | 6.239 | 162.585 | 159.331 | 29.649 |
| Equity: | |||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 315.97 | 157.274 | 157.274 | 27.651 |
| Common Stock
| 0.005 | 0.005 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0 | 0 | 0 |
| Retained Earnings
| -201.724 | -183.022 | -164.83 | -142 | -120.848 | -107.576 | -95.696 | -82.801 | -70.292 | -55.197 | -40.371 | -30.441 | -23.798 | -18.286 | -14.077 |
| Accumulated Other Comprehensive Income/Loss
| -0.184 | -0.006 | 0.381 | 0 | 0 | -0 | -0 | -0 | -0 | 0 | 0 | -315.97 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 577.946 | 572.902 | 368.707 | 364.166 | 359.416 | -0.004 | -0.004 | 350.553 | 349.141 | 346.377 | 342.104 | 340.168 | -156.143 | -156.51 | -27.212 |
| Total Shareholders Equity
| 376.043 | 389.879 | 204.262 | 222.17 | 238.572 | -107.576 | -95.696 | 267.756 | 278.853 | 291.184 | 301.737 | 309.731 | -22.667 | -17.522 | -13.638 |
| Total Equity
| 376.043 | 389.879 | 204.262 | 222.17 | 238.572 | -107.576 | -95.696 | 267.756 | 278.853 | 291.184 | 301.737 | 309.731 | -22.667 | -17.522 | -13.638 |
| Total Liabilities & Shareholders Equity
| 392.461 | 404.741 | 225.857 | 238.358 | 250.012 | -101.311 | -87.344 | 275.985 | 287.118 | 298.971 | 306.701 | 315.97 | 139.918 | 141.809 | 16.011 |